{"id":"clm_B88C88ADFFAE","entity":"abbott-laboratories","predicate":"quarterly_net_income","value":"2,018,000,000 United States dollar","value_json":{"fp":"Q2","fy":2022,"accn":"0001628280-22-020209","form":"10-Q","filed":"2022-08-02","period":"Q2 FY2022","concept":"us-gaap:NetIncomeLoss"},"valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Abbott Laboratories quarterly net income: 2,018,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_B88C88ADFFAE, https://asof.is/claim/clm_B88C88ADFFAE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm.","url":"https://asof.is/claim/clm_B88C88ADFFAE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_55CCFB617DE7","supersedes":["clm_9A8A8D8C7B07"],"first_seen_at":"2026-11-08T16:56:05.679592+00:00","updated_at":"2026-11-08T16:56:13.302197+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-02"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}